Genome Insight Draws $23 Million in Series B Funding to Open the Whole Genome Era for Transforming Precision Medicine

SAN DIEGO–(BUSINESS WIRE)–Genome Insight, a global leader in Whole Genome Sequence analysis and interpretation, announced $23 million in Series B funding. Dunamu & Partners led the financing with participation from InterVest, Signite Partners, KC, and VNTG Corporation, as well as existing investors DSC Investment, Paratus Investment, and Schmidt. The funding will be allocated towards advancing Genome Insight’s data production and curation pipelines that enable scalable investigation of wh
Click here to view original post